Table 3.
Treatment schedule |
Body weight |
Testis |
Epididymis |
Seminal vesicle |
Ventral prostate |
|
---|---|---|---|---|---|---|
(g) | (mg per 100 g bw) | (mg per 100 g bw) | (mg per 100 g bw) | (mg per 100 g bw) | ||
C |
|
215.8 ± 3.47 |
829.2 ± 20.54 |
305.8 ± 14.18 |
510.0 ± 17.45 |
241.7 ± 9.80 |
SD |
20 D |
211.7 ± 2.90 |
775.0 ± 18.87 a |
298.3 ± 13.86 |
488.3 ± 16.33 |
213.3 ± 9.14 |
|
40 D |
210.8 ± 2.59 |
641.7 ± 15.49 a |
275.8 ± 13.67 a |
367.5 ± 13.10 a |
189.2 ± 7.92 a |
|
60 D |
208.3 ± 2.30 |
550.8 ± 13.16 a |
255.8 ± 12.88 a |
249.2 ± 9.34 a |
169.3 ± 6.14 a |
G I |
20 D |
213.3 ± 3.21 |
818.3 ± 19.93 |
309.2 ± 14.39 |
506.0 ± 17.32 |
232.5 ± 9.74 |
|
40 D |
214.2 ± 3.29 |
786.7 ± 18.85 a |
289.2 ± 13.21 a |
479.2 ± 16.42 a |
212.5 ± 9.10 |
|
60 D |
216.5 ± 3.57 |
730.8 ± 17.92 a |
264.2 ± 13.49 a |
436.7 ± 15.81 a |
201.5 ± 8.49 a |
G II |
20 D |
209.0 ± 2.43 |
800.8 ± 19.75 a |
307.5 ± 14.31 |
477.5 ± 16.28 a |
226.7 ± 9.48 |
|
40 D |
211.2 ± 2.84 |
754.2 ± 18.84 a |
278.3 ± 13.79 a |
383.3 ± 13.34 a |
205.0 ± 8.74 |
|
60 D |
208.3 ± 2.24 |
706.7 ± 17.56 a |
209.2 ± 11.90 a |
379.2 ± 13.17 a |
191.7 ± 8.00 a |
G III |
20 D |
216.2 ± 3.42 |
755.0 ± 18.8 a |
307.5 ± 14.34 |
399.2 ± 13.40 a |
208.8 ± 8.94 |
|
40 D |
208.7 ± 2.34 |
679.2 ± 15.95 a |
255.7 ± 12.30 a |
350.0 ± 11.93 a |
195.0 ± 8.25 a |
|
60 D |
216.3 ± 3.45 |
588.3 ± 13.71 a |
178.3 ± 10.02 a |
379.2 ± 13.20 a |
182.3 ± 7.87 a |
R G I |
30 D |
204.0 ± 1.85 |
812.3 ± 20.07 |
308.0 ± 14.39 |
503.3 ± 17.19 |
240.0 ± 9.84 |
R G II |
30 D |
214.7 ± 3.28 |
801.8 ± 19.75 |
300.8 ± 13.93 |
502.5 ± 17.05 |
226.7 ± 9.43 |
R G III | 30 D | 217.0 ± 3.63 | 792.5 ± 19.16 a | 298.2 ± 13.82 | 490.0 ± 16.87 | 206.2 ± 8.94 |
Significance level: a P ≤ 0.01 compared Control.
C- Rats treated with treated with in 2.0 ml 0.5 percent CMC each day for 60 days.
SD- Rats treated with standard drug 50 mg/rat/day/p.o lonidamine.
G I- Rats treated with methanolic bark extract of Aegle marmelos 200 mg/rat/day/p.o.
GII- Rats treated with methanolic bark extract of Aegle marmelos 400 mg/rat/day/p.o.
GIII- Rats treated with methanolic bark extract of Aegle marmelos 600 mg/rat/day/p.o.
RG-I- Rats withdraw from treated for 30 days after 60 days treatment of methanolic bark extract of Aegle marmelos 200 mg/rat/day/p.o.
RG-II- Rats withdraw from treated for 30 days after 60 days treatment of methanolic bark extract of Aegle marmelos 400 mg/rat/day/p.o.
RG-III- Rats withdraw from treated for 30 days after 60 days treatment of methanolic bark extract of Aegle marmelos 600 mg/rat/day/p.o.